Open Label Phase III Duloxetine Study for Stress Urinary Incontinence

PHASE3CompletedINTERVENTIONAL
Enrollment

363

Participants

Timeline

Start Date

September 30, 2001

Study Completion Date

May 31, 2006

Conditions
Urinary Incontinence Stress
Interventions
DRUG

Duloxetine

Trial Locations (1)

PE3 6JG

For additional information regarding investigative sites for this trial contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours EST), or speak with your personal physician., Peterborough

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Boehringer Ingelheim

INDUSTRY

lead

Eli Lilly and Company

INDUSTRY